NCT03863509View on ClinicalTrials.gov

E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease

CompletedOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Tobacco UseE-Cigarette UseCardiovascular DiseasesPulmonary Disease
Interventions
BEHAVIORAL

Cigarettes

smokes daily

BEHAVIORAL

E-Cigarettes

E-cigarette usage \>/= 5 days/week

Trial Locations (1)

53792

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT03863509 - E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease | Biotech Hunter | Biotech Hunter